$BIIB Company News

New Post Public Reply Private Reply Replies (1) Message Board

Apr 22, 2014 at 11:18 AM

$BIIB Company News

Apple, Microsoft are not the keys to this week’s news
7:00 a.m. Today7:00 a.m. April 22, 2014
- Marek Fuchs

Long view on stocks is best during weak earnings season
6:00 a.m. April 20, 2014
- Wallace Witkowski

Biotech misses out on Nasdaq rally, sinks further into bear ground

4:58 p.m. April 14, 2014
- blogs.marketwatch.com

Herbalife sinks on probe fears; Zoe’s surges on debut
4:36 p.m. April 11, 2014
- Ben Eisen

Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap

4:11 p.m. April 7, 2014
- blogs.marketwatch.com

Biotech bargain?
11:43 a.m. April 1, 2014
- The Trading Deck

Facebook, Biogen, Cal-Maine are stocks to watch
5:21 a.m. March 31, 2014
- Victor Reklaitis

U.S. stocks end week with losses
7:17 p.m. March 28, 2014
- Anora Mahmudova

Nasdaq pullback rife with opportunity
2:07 p.m. March 25, 2014
- The Trading Deck

Biotech comeback stalls as Wall Street starts to worry

12:45 p.m. March 25, 2014
- blogs.marketwatch.com

U.S. stocks fall; Nasdaq skids 1.2%
4:40 p.m. March 24, 2014
- Anora Mahmudova

Biotech has second straight sell-off; sector mutual funds take it on chin

10:40 a.m. March 24, 2014
- blogs.marketwatch.com

First Solar extends winning streak; Symantec plunges
3:06 p.m. March 21, 2014
- Ben Eisen

Investors let air out of biotech amid overheating, pricing concerns

1:42 p.m. March 21, 2014
- blogs.marketwatch.com

U.S. stocks rise; S&P 500 positive for the year
4:39 p.m. March 17, 2014
- Anora Mahmudova

Yahoo gains on Alibaba IPO; Plug Power loses momentum
4:17 p.m. March 17, 2014
- Saumya Vaishampayan

Keurig Green Mountain added to S&P 500 index
9:56 a.m. March 15, 2014
- MarketWatch.com

From every angle, technicals point to richer stocks
2:25 p.m. March 11, 2014
- The Trading Deck

Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap

4:03 p.m. March 7, 2014
- blogs.marketwatch.com

Best stocks for legalized marijuana

1:37 p.m. Feb. 27, 2014
- blogs.marketwatch.com

Insider Trading Alert - BIIB, JAZZ And KWK Traded By Insiders

10:15 a.m. Today10:15 a.m. April 22, 2014
- TheStreet.com

Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% - Tale of the Tape

9:39 a.m. Today9:39 a.m. April 22, 2014
- Zacks.com

Zacks Rank #1 Additions for Tuesday - Tale of the Tape

9:30 a.m. Today9:30 a.m. April 22, 2014
- Zacks.com

Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3% - Tale of the Tape

8:51 a.m. Today8:51 a.m. April 22, 2014
- Zacks.com

ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape

8:44 a.m. Today8:44 a.m. April 22, 2014
- Zacks.com

Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

8:41 a.m. Today8:41 a.m. April 22, 2014
- Zacks.com

Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog

6:20 p.m. April 21, 2014
- Zacks.com

Biotech Is Not A Popping Bubble: Buy The Dip While You Can

2:34 p.m. April 21, 2014
- Seeking Alpha

Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog

10:50 a.m. April 21, 2014
- Zacks.com

Gilead heads Citi's 20 best stocks in America

10:28 a.m. April 21, 2014
- Seeking Alpha

3 Stocks Reiterated As A Buy: MU, VZ, BIIB

9:59 a.m. April 21, 2014
- TheStreet.com

Today's Market: Other Potential Buyout Targets For Pfizer

8:54 a.m. April 21, 2014
- Seeking Alpha

Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII; Amunix Could Recieve up to $39M

7:02 a.m. April 21, 2014
- benzinga.com

Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

11:12 a.m. April 18, 2014
- Investors Business Daily

Xenoport's Path Is Long, But The Potential Is There

8:31 p.m. April 17, 2014
- Seeking Alpha

AbbVie Candidate in Pivotal Study - Analyst Blog

12:32 p.m. April 17, 2014
- Zacks.com

Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

9:18 a.m. April 17, 2014
- TheStreet.com

Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog

10:07 a.m. April 16, 2014
- Zacks.com

'Fast Money' Recap: Impressed by Yahoo!

5:00 a.m. April 16, 2014
- TheStreet.com

Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog

11:30 a.m. April 15, 2014
- Zacks.com

Biogen Idec Signs License Agreement With Amunix for XTENylated Factor
VIII
8:02 a.m. April 21, 2014
- Marketwire

RBCC Bioprinting Partner Expands Brand Awareness Campaign
4:28 a.m. April 16, 2014
- BusinessWire - BZX

Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
1:00 p.m. April 15, 2014
- PR Newswire - PRF

Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept
8:00 a.m. April 15, 2014
- PR Newswire - PRF

Biogen Idec to Present New Clinical Data from Its Robust Neurology
Portfolio at AAN Annual Meeting
7:30 a.m. April 14, 2014
- BusinessWire - BZX

JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes Herbalife Business
12:36 a.m. April 14, 2014
- ACCESSWIRE

Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George
Scangos Assume New Posts
9:00 a.m. April 11, 2014
- BusinessWire - BZX

Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer
7:30 a.m. April 10, 2014
- BusinessWire - BZX

Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A
7:06 a.m. April 10, 2014
- Thomson Reuters ONE

Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety
Results from Phase 3 Pediatric Study of Investigational Therapy Eloctate™
(rFVIIIFc) for Hemophilia A
7:00 a.m. April 10, 2014
- BusinessWire - BZX

RBCC and n3D Seek Out Additional Capital
5:00 a.m. April 9, 2014
- BusinessWire - BZX

Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services
8:00 a.m. April 8, 2014
- PR Newswire - PRF

Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution
5:00 a.m. April 3, 2014
- BusinessWire - BZX

Biogen Idec to Report First Quarter 2014 Financial Results on April
23, 2014
4:01 p.m. March 31, 2014
- BusinessWire - BZX

Sobi: US FDA approves Alprolix(TM)
2:05 a.m. March 31, 2014
- GlobeNewswire

Sobi: US FDA approves Alprolix(TM)
2:01 a.m. March 31, 2014
- Thomson Reuters ONE

FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:34 p.m. March 28, 2014
- BusinessWire - BZX

FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:24 p.m. March 28, 2014
- BusinessWire - BZX

Critical Alerts For DirecTV, Biogen Idec, Time Warner, Isis Pharmaceuticals, and DreamWorks Animation Released By InvestorsObserver
9:31 a.m. March 27, 2014
- PR Newswire - PRF

Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit
12:11 p.m. March 26, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

King Risk Partners Expands Mid-Atlantic Presence Boldly

King Risk Partners Grows with New Jersey Acquisition You don't get far in the insurance game without making some bold moves, and King Risk Partners just made a big one—sweeping into New Jersey. They've snagged Conover Beyer Associates Insurance, a firm that's been around longer than some European countries. It's not every day you buy a piece of history, but that's...

Innovative SOV Launches for Offshore Wind Revolution

A New Era for Offshore Wind Operations Mark my words, folks, this launch ain't just some minor milestone swaying gently on the industry seas. ZPMC's 'Wind of Ocean' is about to kickstart a whole new game in Europe's offshore wind space. Built with brains and brawn, this vessel embodies the future of sustainable and efficient offshore operations. The announcement from...

TCL's Energy Vision Unveiled at IFA 2026

TCL's Forward-Thinking Approach at IFA 2026 IFA 2026 in Berlin got a jolt when TCL Industries and TCL Technology rolled out their ambitious plans under the banner "Inspiration Habitat." By blending cutting-edge smart devices with clean energy advancements, TCL is frantically waving red flags for anyone with an eye on future living trends. The Heartbeat of Inspiration...

UGREEN's MagFlow Series: A Game-Changer in Charging

UGREEN Unveils a Cool Revolution in Charging Out in Foxborough, UGREEN is shaking things up at its Smart Living Launch Event. The big reveal? The MagFlow Series, their flagship wireless charging lineup, which promises faster and cooler charging than ever before. UGREEN's taking wireless charging to new heights, and that's got my attention. What Makes MagFlow Stand Out...

LG Electronics Unveils Smart Home Innovations at IFA

Alright, let's dive into this world of shiny new gadgets that LG Electronics has trotted out at the IFA 2026. As European homes get cozier, folks aren't just after any appliance—they're seeking ones that blend smarts, efficiency, and style. So, LG's rolling out seven of their latest and supposedly greatest home appliances, hoping they'll hit the mark with the modern...

Charity's Bold Move: Acquiring Wayfinder for K-12 Impact

Public Charity Expands Into Education Well, here's something that's bound to turn a few heads: a fast-growing public charity has just made its first acquisition in the K-12 sphere by snapping up Wayfinder. The stakes are getting interesting. When a charity starts playing in the acquisition space, you're looking at a change in strategy that deserves close attention. Why...

Armed Security: Balancing Safety with Cost in Rochester

The Decision to Arm: When Business Risks Demand It You know, deciding whether to hire armed security isn't as clear-cut as some folks make it seem. It ain't just about slapping a guard at your door. There's a whole set of chess moves behind it, especially in good ol' Rochester. When you're juggling high-risk operations, like handling valuable inventory or dealing with...

Curaleaf Expands in Florida Amid Rising Cannabis Demand

Curaleaf's Bold Moves in Florida's Ganja Gold Rush Fresh out of the gate, Curaleaf is saddling up for a wild ride into Florida's cannabis frontier. They've just thrown open the doors of their latest dispensary in Riverview, cranking their statewide count up to 77. Now, isn’t that something? If you're tracking these folks, you know that bringing their nationwide total to...

IVD Study Success: Hybrid Monitoring Boosts Oversight

New Strategies for IVD Clinical Studies It's high time we addressed the tangled web of managing in vitro diagnostic (IVD) clinical studies. We're talking about walking a tightrope where sponsors have to juggle regulatory scrutiny, data integrity, and operational efficiency—all while pushing innovation. Simply put, the old ways of doing things just aren't cutting it...

Flex Acquires EPC Power in a $4.4 Billion Deal

An Acquisition with Enormous Implications Folks, if you haven't been paying attention, you're missing out on a seismic shift. EPC Power's sale to Flex for a hefty $4.4 billion isn't just another transaction; it's a clear signal of where the future's headed, especially if you're plugged into the energy or tech sectors. With the way AI is guzzling power like a thirsty...